SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYGN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen Blumenthal who wrote (10)12/16/1996 1:44:00 AM
From: Zencone   of 135
 
I mispelled it, it's "rezulin". There's a small mention at:
nj.com and also at:
biz.yahoo.com; I read about it in the Mercury News and saw it on TV news. It's a new diabetes drug for diabetics who cannot keep their blood sugar under control with insulin. It decreases insulin resistance. Some people are able to stop taking shots altogether with it. It's made by Warner Lambert, but couldn't find it described at their website. I haven't taken the time yet to research further.

I just searched: My Yahoo! Headline Matches (4 - 7 of 7)

New Diabetes Drug Recommended For Approval: The dream of ending insulin injections for diabetics came closer to
realization on Wednesday, with a Food and Drug Administration (FDA) advisory panel recommending approval of the
diabetes-fighting pill Rezulin. - Dec 12 2:37 PM EST

FDA panel backs Warner-Lambert diabetes drug: A federal panel recommended Wednesday that the Food and Drug
Administration approve the Warner-Lambert Co drug Ruzulin to treat the widespread Type II version of diabetes. - Dec
11 3:22 PM EST

Warner-Lambert gains after panel backs drug: Shares in Warner-Lambert Co rose in late trading after a U.S. Food and
Drug Administration advisory panel voted to recommend the agency approve its drug for treating type II diabetes. - Dec
11 3:55 PM EST

FDA panel weighs new Warner-Lambert diabetes drug: Food and Drug Administration scientists said on Wednesday
that trials of the Warner-Lambert Co drug Rezulin seemed effective in treating Type II diabetes, but questioned the
drug's possible side affects. - Dec 11 12:51 PM EST
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News